We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medicis Asks FDA to Stay Solodyn ANDA Approvals
Medicis Asks FDA to Stay Solodyn ANDA Approvals
February 27, 2009
Medicis Pharmaceutical has filed a citizen petition asking the FDA to grant a 30-month stay of approval on certain ANDAs for its acne drug Solodyn.